Back

FDA grants QRX003 second rare pediatric disease designation for peeling skin syndrome

Verifying
  • FDA granted Quoin’s QRX003 a second Rare Pediatric Disease Designation for Peeling Skin Syndrome.
  • Phase 2 plans call for up to 12 pediatric and adult patients in the U.S. and Europe.
  • QRX003 previously received the designation for Netherton Syndrome, according to Quoin.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.